C. David Marsden

Affiliations: 
Neurology King's College (London), London, England, United Kingdom 
Google:
"C. Marsden"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Debono AG, Marsden CD, Asselman P, et al. (2012) Bromocriptine and dopamine receptor stimulation. British Journal of Clinical Pharmacology. 3: 977-82
Pearce RK, Banerji T, Jenner P, et al. (1998) De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 234-41
Rinne UK, Bracco F, Chouza C, et al. (1998) Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group. Drugs. 55: 23-30
Rinne UK, Bracco F, Chouza C, et al. (1997) Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. Neurology. 48: 363-8
Gnanalingham KK, Jenner P, Hunter AJ, et al. (1995) The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Psychopharmacology. 117: 287-297
Blunt SB, Jenner P, Marsden CD. (1993) Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine Movement Disorders. 8: 129-133
Burn DJ, Mark MH, Playford ED, et al. (1992) Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 42: 1894-900
Lange KW, Löschmann PA, Wachtel H, et al. (1992) Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. European Journal of Pharmacology. 212: 247-52
Leenders KL, Salmon EP, Tyrrell P, et al. (1991) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Archives of Neurology. 47: 1290-8
Rose S, Nomoto M, Jenner P, et al. (1990) Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Biochemical Pharmacology. 38: 3677-81
See more...